Spore Powder of Ganoderma lucidum Improves Cancer-Related Fatigue in Breast Cancer Patients Undergoing Endocrine Therapy: A Pilot Clinical Trial

Table 4

Patients' functioning and global quality of life scores as measured by the EORTC QLQ-C30.

Subscale	Experimental group (𝑛=25)	Control group (𝑛=23)
Functional scales
Physical functioning
Week 0	63.7±25.9	64.0±27.1
Week 4	78.2±26.1^**##	64.5±28.7
Role functioning
Week 0	65.2±33.6	68.1±31.2
Week 4	79.1±31.1	69.3±32.4
Emotional functioning
Week 0	61.3±30.2	62.2±32.5
Week 4	79.5±31.5^**##	64.3±31.8
Social Functioning
Week 0	72.4±29.1	74.3±28.6
Week 4	76.1±26.8	75.5±27.9
Cognitive functioning
Week 0	65.6±24.3	66.4±23.2
Week 4	75.1±26.5^*#	68.3±26.3
Global Quality of Life
Week 0	55.8±22.9	56.6±23.0
Week 4	68.9±21.4^**##	57.7±24.2

* 𝑃<0.05 versus Week 0 of experimental group.
** 𝑃<0.01 versus Week 0 of experimental group.
^#𝑃<0.05 versus week 4 of control group.
^##𝑃<0.01 versus week 4 of control group.